Breast cancer jab 'prevents the disease in 75% of cases': Treatment could spare thousands of women the trauma of surgery

The main beneficiaries of the jab developed in the U.S. are likely to be women with a very early form of breast cancer called ductal carcinoma in situ, or DCIS.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news